Annual General Meeting of shareholders of InterCure Ltd.roman4682Nov 20, 20240 min readUpdated: Feb 2711-20-2024 .pdfDownload PDF • 226KB
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million